NGF/γ-IFN inhibits androgen-independent prostate cancer and reverses androgen receptor function through downregulation of FGFR2 and decrease in cancer stem cells

Stem Cells Dev. 2012 Dec 10;21(18):3372-80. doi: 10.1089/scd.2012.0121. Epub 2012 Jul 30.

Abstract

Androgen-independent prostate cancer (AIPC) is difficult to treat. Present study is to explore the inhibitory effect of a cytokine environment on AIPC and its mechanism. We utilized nerve growth factor (NGF)/γ-interferon (γ-IFN) to change the cytokine environment. Animal models and 2 androgen receptor (AR)-negative prostate cancer cell lines were used to evaluate the effect of NGF/γ-IFN. Flow cytometry, immunocytochemistry, western blotting, Tunel assay, colony formation efficiency, gene microarray, and in vivo bioluminescence were used to discern the mechanisms within NGF/γ-IFN that effect the environment. In vitro, NGF/γ-IFN effectively inhibited the proliferation of AIPC cell lines and promoted the apoptosis of the cancer cells. In vivo, NGF/γ-IFN suppressed the growth and metastasis of a tumor mass that arose from the AIPC cell line. After NGF/γ-IFN treatment, the AR-negative cell lines re-expressed AR and were then able to respond to the androgen. Contrary to expectations, the proliferation of cells was inhibited after dihydrotestosterone was added, and the results indicated that NGF/γ-IFN decreased the proportion of cancer stem cells. NGF/γ-IFN worked mainly through the downregulation of fibroblast growth factor receptor 2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Cell Count
  • Cell Line, Tumor
  • Cell Proliferation
  • Dihydrotestosterone / pharmacology
  • Down-Regulation
  • Humans
  • Interferon-gamma / metabolism
  • Interferon-gamma / pharmacology*
  • Male
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Neoplasm Metastasis
  • Neoplasm Transplantation
  • Neoplastic Stem Cells / cytology
  • Nerve Growth Factor / metabolism
  • Nerve Growth Factor / pharmacology*
  • Prostatic Neoplasms / drug therapy*
  • Receptor, Fibroblast Growth Factor, Type 2 / biosynthesis*
  • Receptors, Androgen / drug effects
  • Receptors, Androgen / metabolism*
  • Transplantation, Heterologous
  • Wnt1 Protein / biosynthesis
  • Wnt2 Protein / biosynthesis

Substances

  • NGF protein, human
  • Receptors, Androgen
  • Wnt1 Protein
  • Wnt1 protein, mouse
  • Wnt2 Protein
  • Dihydrotestosterone
  • Interferon-gamma
  • Nerve Growth Factor
  • FGFR2 protein, human
  • Receptor, Fibroblast Growth Factor, Type 2